CFDA 93.799 · retired · Funded this fiscal year
CARA ACT Comprehensive Addition and Recovery Act of 2016
CENTERS FOR DISEASE CONTROL AND PREVENTION · HEALTH AND HUMAN SERVICES, DEPARTMENT OF · Program page ↗
Objective
Grants awarded through the CARA Act are intended as an enhancement to current or formerly funded Drug-Free Communities (DFC) Support Program grant award recipients as established community-based youth substance use prevention coalitions capable of effecting community-level change. For the purposes of the DFC Support Program, a coalition is defined as a community-based formal arrangement for cooperation and collaboration among groups or sectors of a community in which each group retains its identity, but all agree to work together toward a common goal of building a safe, healthy, and drug-free community. CARA grant award recipients, also referred to as “recipients,” are expected to conduct the day-to-day operations of the grant program. CARA recipients are not permitted to serve as a conduit for CARA funds passing through them or to another agency. Coalitions receiving CARA Act funds, as current or formerly funded DFC recipients, are expected to work with leaders in their communities to identify and address local youth opioid, methamphetamine, and/or prescription medication abuse and create sustainable community-level change. Additionally, recipients are expected to implement comprehensive community-wide strategies.
Who Can Apply
- Nonprofit Organization
The statutory authority for this program, 42 USC 1536 of the Comprehensive Addiction and Recovery Act, limits eligibility to domestic public and private nonprofit entities that are current or former Drug-Free Communities (DFC) Support Program recipients. Eligible applicants are community-based coalitions addressing local youth opioid, methamphetamine, and/or prescription medication abuse. Reference posted NOFOs available on grants.gov.
Who Benefits
- Nonprofit Organization
The purpose of this program is to prevent and reduce the abuse of opioids or methamphetamines and the abuse of prescription medications among youth ages 12-18 in communities throughout the United States *For the purposes of this NOFO, “youth” is defined as individuals 18 years of age and younger.
Assistance Types
- Grant
Program Contact
buv3@cdc.gov
770.488.3703